Sen. James M. Inhofe sold CRISPR Therapeutics AG (CRSP)
Sen. James M. Inhofe (R-OK) · $15K–$50K · traded Jun 19, 2018
- Transaction
- Sold (partial)
- Amount
- $15K–$50K
- Owner
- The member
- Traded
- Jun 19, 2018
- Disclosed
- Jun 20, 2018
- Days to disclose
- 1
- Asset type
- Stock
- As filed
- CRISPR Therapeutics AG
- Industry
- Biotechnology · Healthcare
Other trades in this filing
- Jun 20, 2018$50K–$100K
Sold (full) Bristol-Myers Squibb Company BMY
$50K–$100K · Traded Jun 4, 2018 · disclosed Jun 20, 2018
- Jun 20, 2018$15K–$50K
Sold (partial) Continental Resources CLR
$15K–$50K · Traded May 29, 2018 · disclosed Jun 20, 2018
Recent Congress trades in CRSP
- Jan 15, 2021$1K–$15K
Sen. James M. Inhofe (R-OK)
Sold (partial) CRISPR Therapeutics AG CRSP
$1K–$15K · Traded Jan 5, 2021 · disclosed Jan 15, 2021
- Dec 23, 2020$50K–$100K
Sen. James M. Inhofe (R-OK)
Sold (partial) CRISPR Therapeutics AG CRSP
$50K–$100K · Traded Dec 22, 2020 · disclosed Dec 23, 2020
- Nov 8, 2017$15K–$50K
Sen. James M. Inhofe (R-OK)
Bought CRISPR Therapeutics AG CRSP
$15K–$50K · Traded Oct 19, 2017 · disclosed Nov 8, 2017
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.